Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort study

Lalita Priyamvada, Faisal S Minhaj, Toutou Likafi, Elisabeth Pukuta, Elisabeth Muyamuna, William C Carson, Margaret Moriarty, Sergio Rodriguez, Taina Joseph, Joelle Kabamba, Gaston Kokola, Robert Shongo Lushima, Jean-Jacques Muyembe-Tamfum, Christine M Hughes, Brett W Petersen, Yon Yu, Agam Rao, Andrea M McCollum, Didine K Kaba, Beatrice U Nguete, Panayampalli S Satheshkumar, Michael B Townsend

Open source

DOI
10.1016/s1473-3099(26)00001-0
Published
2026-06
Container
The Lancet Infectious Diseases
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-26-00001-0,
  title = {Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort study},
  author = {Lalita Priyamvada and Faisal S Minhaj and Toutou Likafi and Elisabeth Pukuta and Elisabeth Muyamuna and William C Carson and Margaret Moriarty and Sergio Rodriguez and Taina Joseph and Joelle Kabamba and Gaston Kokola and Robert Shongo Lushima and Jean-Jacques Muyembe-Tamfum and Christine M Hughes and Brett W Petersen and Yon Yu and Agam Rao and Andrea M McCollum and Didine K Kaba and Beatrice U Nguete and Panayampalli S Satheshkumar and Michael B Townsend},
  year = {2026},
  journal = {The Lancet Infectious Diseases},
  doi = {10.1016/s1473-3099(26)00001-0},
  url = {https://doi.org/10.1016/s1473-3099(26)00001-0}
}

RIS

TY  - JOUR
TI  - Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort study
AU  - Lalita Priyamvada
AU  - Faisal S Minhaj
AU  - Toutou Likafi
AU  - Elisabeth Pukuta
AU  - Elisabeth Muyamuna
AU  - William C Carson
AU  - Margaret Moriarty
AU  - Sergio Rodriguez
AU  - Taina Joseph
AU  - Joelle Kabamba
AU  - Gaston Kokola
AU  - Robert Shongo Lushima
AU  - Jean-Jacques Muyembe-Tamfum
AU  - Christine M Hughes
AU  - Brett W Petersen
AU  - Yon Yu
AU  - Agam Rao
AU  - Andrea M McCollum
AU  - Didine K Kaba
AU  - Beatrice U Nguete
AU  - Panayampalli S Satheshkumar
AU  - Michael B Townsend
PY  - 2026
JO  - The Lancet Infectious Diseases
DO  - 10.1016/s1473-3099(26)00001-0
UR  - https://doi.org/10.1016/s1473-3099(26)00001-0
ER  - 

APA

Priyamvada, L., Minhaj, F. S., Likafi, T., Pukuta, E., Muyamuna, E., Carson, W. C., Moriarty, M., Rodriguez, S., Joseph, T., Kabamba, J., Kokola, G., Lushima, R. S., Muyembe-Tamfum, J., Hughes, C. M., Petersen, B. W., Yu, Y., Rao, A., McCollum, A. M., Kaba, D. K., Nguete, B. U., Satheshkumar, P. S., & Townsend, M. B. (2026). Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort study. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(26)00001-0

Source records